Nishikawa, Yoshitaka http://orcid.org/0000-0003-3313-1990
Hoshino, Nobuaki
Horimatsu, Takahiro
Funakoshi, Taro
Hida, Koya
Sakai, Yoshiharu
Muto, Manabu
Nakayama, Takeo
Article History
Received: 27 December 2019
Accepted: 27 April 2020
First Online: 24 May 2020
Compliance with ethical standards
:
: MM received research funding outside the submitted work from TAIHO PHARMACEUTICAL CO., LTD., Nissha Co., Ltd., KUBIX Inc., SYSMEX CORPORATION, Thyas Co., Ltd., ONO PHARMACEUTICAL CO., LTD., ACTmed Co., LTD., Eisai Co., Ltd., RIKEN GENESIS CO., LTD., CHUGAI PHARMACEUTICAL CO., LTD., Bio-xcelerator K.K., Gtheranostics Co., Ltd., Yakult Honsha Co., Ltd., IQVIA Services Japan K.K., Parexel International Inc., MSD K.K., and Meiji Seika Pharma Co., Ltd; and scholarship donation outside the submitted work from ARK INNOVATION Inc., ONO PHARMACEUTICAL CO., LTD, AYUMI Pharmaceutical Corporation, Showa Yakuhin Kako Co.,Ltd., CHUGAI PHARMACEUTICAL CO., LTD., INTAGE Healthcare Inc., Cyber Laboratory Inc., Gtheranostics Co., Ltd., and Yakult Honsha Co.,Ltd. TN received honoraria outside the submitted work from ONO PHARMACEUTICAL CO., LTD., Nippon Boehringer Ingelheim Co., Ltd., and Pfizer Japan Inc. YN, NH, TH, TF, KH, and YS declare no conflict of interest.